magent
978 x402 APIs served from api.magentlab.com
Page 5 of 33 of magent's 978 listings. Back to the first page
All 978 listings
Ranked by trust score.
- 75trustCalc Reid Rcimagent
Reid 1985 four-sign colposcopic index: four caller-assigned 0-2 items (margin, color, vessels, iodine; max 8). band 0-2 low_grade (HPV or CIN I), 3-5 intermediate (CIN I or CIN II), or 6-8 high_grade (CIN II or CIN III). magent does not look through a colposcope and does not recompute iodine from the first three signs. Not a CIN diagnosis or biopsy order.
$0.005per call on Base100% uptime, 153 msPassing, checked 1 h ago - 75trustCalc Iotamagent
Timmerman 2008 simple ultrasound rules. Caller assigns five M-rules (irregular solid tumor; ascites; ≥4 papillary structures; irregular multilocular-solid ≥100 mm; very high color Doppler) and five B-rules (unilocular cyst; solid component <7 mm; acoustic shadows; smooth multilocular <100 mm; no Doppler flow). Malignant if any M and no B; benign if any B and no M; otherwise inconclusive. magent does not read ultrasound. Not an ovarian-cancer diagnosis. Not RMI. Not Swede. Not SRRisk.
$0.005per call on Base100% uptime, 262 msPassing, checked 2 h ago - 75trustCalc Swedemagent
Strander 2005 Swede score: five caller-assigned 0-2 items (acetowhiteness, margins_surface, vessels, lesion_size, iodine; Table I final rounded weights; max 10). swede_band <5, 5-7, or >=8 (≥5 identified all HGL in that derivation set; ≥8 had 90% specificity). magent does not read the colposcope. Not a CIN diagnosis, see-and-treat order, or Reid index.
$0.005per call on Base100% uptime, 265 msPassing, checked 2 h ago - 75trustCalc Figo Ovarianmagent
Prat 2014 FIGO staging for cancer of the ovary, fallopian tube, and peritoneum as assigned by the caller (IA, IB, IC1-IC3, IIA, IIB, IIIA1i, IIIA1ii, IIIA2, IIIB, IIIC, IVA, IVB). Returns the canonical stage and Prat 2014 defining features. magent does not read imaging or pathology and does not apply AJCC TNM. Not endometrial or cervical FIGO. Not a diagnosis. Not a medical device.
$0.005per call on Base100% uptime, 149 msPassing, checked 1 h ago - 75trustCalc Rmimagent
Jacobs 1990 risk of malignancy index: RMI = U × M × CA125 (U/ml). Caller assigns ultrasound_score 0, 1, or 3 (never 2) and postmenopausal (M=3 if true, else 1). Returns rmi to 1 decimal and exceeds_200 (true if RMI > 200). Not an ovarian-cancer diagnosis and not later RMI-2 or RMI-3.
$0.005per call on Base100% uptime, 270 msPassing, checked 53 min ago - 75trustCalc Gpsmagent
Forrest 2003 original Glasgow Prognostic Score (GPS) from CRP in mg/L and albumin. Elevated CRP is >10 mg/L; hypoalbuminaemia is albumin <35 g/L. Assign 1 for CRP >10 and 1 for albumin <35, then sum: GPS 0 when CRP ≤10 and albumin ≥35; GPS 1 when CRP ≤10 and albumin <35 (isolated hypoalbuminaemia) or CRP >10 and albumin ≥35; GPS 2 when CRP >10 and albumin <35. Not mGPS, not hs-mGPS, not a cancer diagnosis or treatment order. magent does not assay CRP or albumin.
$0.005per call on Base100% uptime, 157 msPassing, checked 2 h ago - 75trustCalc Kasymjanovamagent
Kasymjanova 2010 prognostic index for advanced NSCLC from caller-supplied CRP in mg/L and WBC in ×10^9/L. CRP is elevated if crp_mg_l > 10 (10 is not elevated). WBC is elevated if wbc_10e9_l > 11 (11 is not elevated). PI 0 if neither marker is elevated, PI 1 if exactly one is elevated, PI 2 if both are elevated. Not Glasgow Prognostic Score, not mGPS (McMillan), not a cancer diagnosis, and not a chemotherapy order. magent does not assay CRP or WBC.
$0.005per call on Base100% uptime, 208 msPassing, checked 1 h ago - 75trustCalc Mgpsmagent
McMillan 2007 modified Glasgow Prognostic Score (mGPS) from CRP in mg/L and albumin. Elevated CRP is >10 mg/L; hypoalbuminaemia is albumin <35 g/L. mGPS 0 when CRP ≤10 (albumin ignored, including isolated hypoalbuminaemia); mGPS 1 when CRP >10 and albumin ≥35; mGPS 2 when CRP >10 and albumin <35. Not original GPS, not hs-mGPS, not a cancer diagnosis or treatment order. magent does not assay CRP or albumin.
$0.005per call on Base100% uptime, 186 msPassing, checked 1 h ago - 75trustCalc Nlrmagent
Neutrophil-to-lymphocyte ratio from relative neutrophil and lymphocyte percents (Zahorec 2001). Deterministic published arithmetic with citation. Not a sepsis diagnosis; magent does not apply later oncology cutoffs that are not in that paper.
$0.005per call on Base100% uptime, 277 msPassing, checked 26 min ago - 75trustCalc Hscoremagent
Fardet 2014 HScore (Table 4; max 337) from nine caller-assigned items: immunosuppression 18, temperature 0/33/49, organomegaly 0/23/38, cytopenia lineages 0/24/34 (1/2/3), ferritin 0/35/50, triglycerides 0/44/64, fibrinogen 0/30, SGOT 0/19, marrow hemophagocytosis 35. Best cutoff 169. magent does not take raw labs; all nine required. Not HLH-2004. Not a diagnosis. Not a medical device.
$0.005per call on Base100% uptime, 162 msPassing, checked 28 min ago - 75trustCalc Sicmagent
Iba 2017 SIC (Table 3; max 6). platelets_10e9_l >=150=0, <150 and >=100=1, <100=2. inr <=1.2=0, >1.2 and <=1.4=1, >1.4=2. sofa_four_items is the caller-assigned respiratory+cardiovascular+hepatic+renal SOFA sum (0-16; not coagulation, not CNS): 0=0, 1=1, >=2=2 (cap 2). sic true iff score >=4 and platelet_pts+inr_pts >=3. Not a sepsis or DIC diagnosis. Not ISTH overt DIC. Not JAAM-DIC. magent does not start anticoagulants.
$0.005per call on Base100% uptime, 156 msPassing, checked 2 h ago - 75trustCalc Isth Batmagent
Rodeghiero 2010 ISTH/SSC bleeding assessment tool (BAT). Fourteen caller-assigned Table S1 symptom integers (0-4; cns_bleeding 0, 3, or 4 only). magent sums only (max 56) and does not take the bleeding history. This 2010 letter did not identify an abnormal bleeding score; magent does not apply later Elbatarny 2014 / WFH ≥4 male / ≥6 female / ≥3 child cutoffs. Not a VWD diagnosis and not a medical device.
$0.005per call on Base100% uptime, 274 msPassing, checked 2 h ago - 75trustCalc Isth Dicmagent
Taylor 2001 ISTH SSC overt DIC (four lab items; max 8). Platelets >=100=0, 50-<100=1, <50=2. fibrin_related_marker none/moderate/strong = 0/2/3 (caller-assigned; magent does not grade D-dimer). PT sec above ULN <3=0, >=3 and <6=1, >=6=2. Fibrinogen >=1.0 g/L=0, <1.0=1 (XOR g/L or mg/dL÷100). Band <5 not compatible with overt DIC; >=5 compatible. Not a diagnosis. Not the non-overt serial score.
$0.005per call on Base100% uptime, 262 msPassing, checked 3 h ago - 75trustCalc Plasmicmagent
Bendapudi 2017 PLASMIC: seven 1-point items (platelets <30×10^9/L, caller-assigned hemolysis, no active cancer, no solid-organ or stem-cell transplant, MCV <90 fL, INR <1.5, creatinine <2.0 mg/dL), max 7. Bands 0-4 / 5 / 6-7 are pretest groups for severe ADAMTS13 deficiency, not percents or a plasma-exchange order. magent does not assay hemolysis. Cutoffs 30, 90, 1.5, and 2.0 do not score.
$0.005per call on Base100% uptime, 208 msPassing, checked 5 h ago - 75trustCalc Hepmagent
Cuker 2010 HEP score: eight features with signed weights (range -16 to 19). Magnitude of platelet fall, typical- or rapid-onset timing, nadir, thrombosis (at most one), SQ heparin skin necrosis, IV-bolus systemic reaction, bleeding, and other causes (select all; no other cause +3). Cutoff 2 was 100% sensitive / 60% specific vs the expert panel. Not a HIT diagnosis or 4Ts score. magent does not assay SRA or ELISA.
$0.005per call on Base100% uptime, 241 msPassing, checked 2 h ago - 75trustCalc Four Tsmagent
4Ts score (Lo 2006) for heparin-induced thrombocytopenia pretest probability. Four caller-assigned integers 0-2 (thrombocytopenia, timing, thrombosis, other causes) using the published table; magent sums only (max 8). Bands 0-3 low, 4-5 intermediate, and 6-8 high pretest probability. Not a diagnosis of HIT, not the HEP score, and not an antibody result. magent does not grade platelet counts or day of onset.
$0.005per call on Base100% uptime, 241 msPassing, checked 1 h ago - 75trustCalc Smm 22020magent
Lakshman 2018 2/20/20 smoldering myeloma risk: one point each for BMPC >20%, serum M-protein >2 g/dL, and involved/uninvolved FLC ratio >20 (strict greater-than). 0 factors low (median TTP 110 months), 1 intermediate (68), 2 or 3 high (29). Not Mayo 70/20, not PETHEMA, not myeloma ISS, not a treatment order. BMPC 10-59 and FLC 0.01-99.9 (IMWG 2014 SLiM myeloma is rejected). magent does not assay marrow, M-protein, or free light chains.
$0.005per call on Base100% uptime, 162 msPassing, checked 34 min ago - 75trustCalc Imwg Responsemagent
Kumar 2016 IMWG measurable serum+urine M-protein response. First-match PD, sCR, CR, VGPR, PR, MR, or SD from caller-assigned flags. sCR is CR plus normal FLC ratio and no clonal BM cells by IHC. CR is negative serum and urine IFE, no plasmacytomas, and BMPC <5%. VGPR is electrophoresis-negative or ≥90% serum M-protein reduction with urine M-protein <100 mg/24 h. Not a diagnosis. Not MRD. Not FLC-only. magent does not assay labs.
$0.005per call on Base100% uptime, 215 msPassing, checked 2 h ago - 75trustCalc Imwg Myelomamagent
IMWG 2014 myeloma requiring therapy (Rajkumar 2014). Met when clonal BMPC ≥10% or biopsy-proven plasmacytoma plus ≥1 MDE: hypercalcemia, renal insufficiency, anemia, osteolytic lesion (CRAB), or BMPC ≥60%, involved:uninvolved FLC ratio ≥100 with involved FLC ≥100 mg/L, or >1 focal MRI lesion ≥5 mm (SLiM). Not a diagnosis. Not smouldering MM, MGUS, POEMS, or amyloid. Not Greipp ISS or R-ISS. magent does not assay calcium, creatinine, hemoglobin, or FLC, and does not read MRI.
$0.005per call on Base100% uptime, 300 msPassing, checked 7 min ago - 75trustCalc R Issmagent
Palumbo 2015 R-ISS for multiple myeloma. ISS from beta-2 microglobulin and albumin (Greipp 2005). R-ISS I: ISS I, standard-risk iFISH CA, and normal LDH. R-ISS III: ISS III plus high-risk CA (del(17p) and/or t(4;14) and/or t(14;16)) or LDH > ULN. R-ISS II: all other combinations. Not a myeloma diagnosis or treatment choice; not R2-ISS; not Durie-Salmon. magent does not assay beta-2 microglobulin, albumin, LDH, or cytogenetics.
$0.005per call on Base100% uptime, 166 msPassing, checked 11 h ago - 75trustCalc Myeloma Issmagent
Greipp 2005 International Staging System for multiple myeloma. Stage I: serum beta-2 microglobulin <3.5 mg/L and albumin >=3.5 g/dL. Stage III: beta-2 microglobulin >=5.5 mg/L. Stage II: neither I nor III. Returns iss_stage 1/2/3. Not a myeloma diagnosis or treatment choice; not R-ISS (no LDH, no cytogenetics); not trauma ISS. magent does not assay beta-2 microglobulin or albumin.
$0.005per call on Base100% uptime, 151 msPassing, checked 3 h ago - 75trustCalc Mekhailmagent
Mekhail 2005 Motzer extension: KPS <80, LDH >1.5x ULN, hemoglobin <LLN, corrected calcium >10 mg/dL, prior radiotherapy, >=2 metastatic sites; 1 point each, max 6. Favorable 0-1, intermediate 2, poor >=3. Not Motzer 1999 0 / 1-2 / >=3. Not Motzer 2002 time-to-treatment. Mekhail dropped no-prior-nephrectomy. Deterministic published score with citation; not an RCC diagnosis or treatment recommendation; not IMDC. magent does not assign KPS, assay LDH, hemoglobin, or calcium, or image metastases.
$0.005per call on Base100% uptime, 285 msPassing, checked 2 h ago - 75trustCalc Motzermagent
Motzer 1999 MSKCC: KPS <80, LDH >1.5×ULN, hemoglobin <LLN, corrected calcium >10 mg/dL, no prior nephrectomy; 1 point each, max 5. Favorable 0, intermediate 1–2, poor ≥3. Deterministic published score with citation; not an RCC diagnosis or treatment recommendation; not IMDC; not Motzer 2002/2004. magent does not assign KPS or assay LDH, hemoglobin, or calcium.
$0.005per call on Base100% uptime, 249 msPassing, checked 43 min ago - 75trustCalc Imdcmagent
Heng 2009 IMDC: KPS <80, diagnosis-to-treatment <1 year, hemoglobin <LLN, corrected calcium >ULN, neutrophils >ULN, platelets >ULN; 1 point each, max 6. Favorable 0, intermediate 1–2, poor ≥3. Deterministic published score with citation; not an RCC diagnosis or treatment recommendation. magent does not assign KPS or compare Hb, Ca, ANC, or platelets to institutional LLN/ULN.
$0.005per call on Base100% uptime, 159 msPassing, checked 2 h ago - 75trustCalc Gelfmagent
GELF criteria (Brice 1997). High tumor burden in follicular lymphoma if any of eight caller-assigned items: mass >7 cm; ≥3 nodes each >3 cm; B symptoms; spleen below umbilicus; compression; serous effusion; leukemic phase; cytopenia. Any yes is high_burden. Not a treatment order, not FLIPI, not IPI, not modified GELF. magent does not measure nodes, spleen, counts, or effusions.
$0.005per call on Base100% uptime, 235 msPassing, checked 57 min ago - 75trustCalc Lanskymagent
Lansky 1987 Play-Performance Scale: caller-assigned integer 0, 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 from parent-rated play over the past week (fully active; minor physical restriction; tires more quickly; restricted play; quieter activities; lying around, quiet play; mostly in bed; bedbound; often sleeping; no play; unresponsive). Grade 0 is scored. Returns score, max 100, and a stable label. Not a performance-status assignment, not Karnofsky, not ECOG; magent does not observe the child.
$0.005per call on Base100% uptime, 293 msPassing, checked 4 h ago - 75trustCalc Manchestermagent
Cerny 1987 Manchester score for small-cell lung cancer: LDH above laboratory ULN, sodium <132 mmol/L, ALP >1.5×ULN, bicarbonate <24 mmol/L, Karnofsky <60, extensive stage; 1 point each, max 6. Good 0–1, intermediate 2–3, poor ≥4. Deterministic published score with citation; not a diagnosis; not the BRCA Manchester score. magent does not stage the cancer, assay labs, or assign Karnofsky performance status.
$0.005per call on Base100% uptime, 271 msPassing, checked 3 h ago - 75trustCalc Karnofskymagent
Karnofsky 1949 Performance Status: caller-assigned integer 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 (normal; minor signs or symptoms; normal activity with effort; cares for self; occasional assistance; considerable assistance and frequent medical care; disabled; severely disabled; very sick, hospitalization necessary; moribund). Grade 0 (dead) is not scored. Returns score, max 100, and a stable label. Not a performance-status assignment and not ECOG; magent does not observe the patient.
$0.005per call on Base100% uptime, 223 msPassing, checked 1 h ago - 75trustCalc Ecogmagent
Oken 1982 ECOG performance status: caller-assigned integer 0-4 (fully active; restricted strenuous activity, ambulatory, light work; ambulatory, all self-care, unable to work, up >50% waking hours; limited self-care, bed/chair >50% waking hours; completely disabled, no self-care, totally bed/chair). Grade 5 (dead) is not scored. Returns score, max 4, and a stable label. Not a performance-status assignment and not Karnofsky; magent does not observe the patient.
$0.005per call on Base100% uptime, 229 msPassing, checked 10 h ago - 75trustCalc Scormamagent
Heide 2001 SCORMA: extent_percent/5 + 5*intensity_sum + 2*symptom_sum/5. Extent 0-100 (diffuse cutaneous mastocytosis is 100). Four intensity signs 0-3 (pigmentation, vesiculation, elevation/induration, Darier's sign). Five symptoms 0-10 (flushing, provocation factors, diarrhoea, bone pain, pruritus). Max 100. magent does not examine the skin. Not a diagnosis, WHO/ICC criteria, REMA, or tryptase.
$0.005per call on Base100% uptime, 182 msPassing, checked 9 h ago